Improvements in Pain and Fatigue in Bimekizumab
HTML-код
- Опубликовано: 7 фев 2025
- Dr. Philip Mease discusses abstract 2368 Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies, presented at the 2024 ACR Convergence meeting in Washington, DC.
